Search

Search Results
Results 621 - 630 of 788 for Male breast cancer
  • Lutathera
    Drug - 27 Nov 2025
    Consumer Medicine Information (CMI) about Lutathera intended for persons living in Australia.
  • Proquad
    Drug - 12 Nov 2025
    Consumer Medicine Information (CMI) about Proquad intended for persons living in Australia.
  • Gardasil 9
    Drug - 2 Nov 2025
    Consumer Medicine Information (CMI) about Gardasil 9 intended for persons living in Australia.
  • Tafinlar
    Drug - 27 Oct 2025
    Consumer Medicine Information (CMI) about Tafinlar intended for persons living in Australia.
  • Scientists find hundreds of genes that behave like light switches
    News - 19 Jun 2025
    Gene expression, where cells use the genetic information encoded in DNA to produce proteins, has been thought of as a dimmer light.
  • New AI tool detects elevated heart disease risk in women using ECG
    News - 25 Feb 2025
    A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG).
  • New medication-based approach reverses inguinal hernias in mice
    News - 5 Feb 2025
    By age 75, a noteworthy 50% of men develop an inguinal (groin) hernia - a bulge that results from soft tissue pushing through a weak spot in the abdominal muscles.
  • Pomalyst
    Drug - 29 Jan 2025
    Consumer Medicine Information (CMI) about Pomalyst intended for persons living in Australia.
  • Revlimid
    Drug - 23 Jan 2025
    Consumer Medicine Information (CMI) about Revlimid intended for persons living in Australia.
  • Alecensa
    Drug - 6 Jan 2025
    Consumer Medicine Information (CMI) about Alecensa intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback